|68.69|| +0.08 / +0.12%|
STERIS Corp. engages in the provision of infection prevention and other procedural products & services, focused on healthcare, pharmaceutical, and research industries. It operates through three segments: Healthcare, Life Sciences and STERIS Isomedix Services. The Healthcare segment manufactures and sells capital equipment, accessory, consumables, information support and service solutions to healthcare providers, including acute care hospitals and surgery and gastrointestinal centers. The Life Sciences segment serves segment manufactures and sells a broad range of capital equipment, formulated cleaning chemistries, and service solutions to pharmaceutical companies and private and public research facilities around the globe. The STERIS Isomedix Services segment provides ethylene oxide and irradiation services on a contract basis through a network of facilities in North America. The company was founded by Raymond C. Kralovic and Edward T. Schneider in August 9, 1985 and is headquartered in Mentor, OH.
|Walter M. Rosebrough||President, Chief Executive Officer & Director|
|Michael J. Tokich||Chief Financial Officer, Treasurer & Senior VP|
|Peter A. Burke||Chief Technology Officer & Senior Vice President|
|Kathleen Lynn Bardwell||Chief Compliance Officer & Senior Vice President|
|Robert E. Moss||Group President-Isomedix Services & Senior VP|